Legal & General Group Plc Trims Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Legal & General Group Plc lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 423,490 shares of the medical instruments supplier’s stock after selling 26,846 shares during the period. Legal & General Group Plc’s holdings in DENTSPLY SIRONA were worth $8,038,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Cerity Partners LLC grew its holdings in shares of DENTSPLY SIRONA by 268.5% in the fourth quarter. Cerity Partners LLC now owns 65,588 shares of the medical instruments supplier’s stock valued at $1,294,000 after purchasing an additional 47,788 shares in the last quarter. Federated Hermes Inc. increased its position in shares of DENTSPLY SIRONA by 0.5% during the fourth quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier’s stock worth $3,213,000 after acquiring an additional 915 shares during the period. Quadrant Capital Group LLC boosted its holdings in DENTSPLY SIRONA by 197.1% in the fourth quarter. Quadrant Capital Group LLC now owns 5,252 shares of the medical instruments supplier’s stock valued at $100,000 after purchasing an additional 3,484 shares during the period. Envestnet Asset Management Inc. grew its stake in DENTSPLY SIRONA by 18.6% during the 4th quarter. Envestnet Asset Management Inc. now owns 453,801 shares of the medical instruments supplier’s stock worth $8,613,000 after purchasing an additional 71,213 shares in the last quarter. Finally, Bryce Point Capital LLC purchased a new stake in DENTSPLY SIRONA during the 4th quarter worth about $1,216,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on XRAY. Wells Fargo & Company lowered their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Morgan Stanley cut shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price target for the company. in a report on Tuesday. Evercore ISI reaffirmed an “in-line” rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Mizuho lowered their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research note on Thursday, March 13th. Finally, Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their price target for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Thirteen investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $22.58.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $12.83 on Friday. The business has a 50 day simple moving average of $15.72 and a 200-day simple moving average of $18.82. The company has a market capitalization of $2.56 billion, a P/E ratio of -6.20, a PEG ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $31.00. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.99%. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Insider Activity

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business’s stock in a transaction dated Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.